Amicus Therapeutics Inc (FRA:AM6)
€ 9.3 0.2 (2.2%) Market Cap: 2.82 Bil Enterprise Value: 3.01 Bil PE Ratio: 0 PB Ratio: 16.43 GF Score: 78/100

Amicus Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 12, 2021 / 05:15PM GMT
Release Date Price: €7.8 (+1.96%)
Tazeen Ahmad
BofA Securities, Research Division - VP

Good afternoon, everyone. Thanks for joining us again at the Bank of America Healthcare Conference. It's our pleasure to have our next presenting company, Amicus.

Presenting for Amicus today are Brad Campbell and Jeff Castelli. Brad and Jeff, good afternoon. Nice to have you with us again.

Bradley L. Campbell
Amicus Therapeutics, Inc. - President, COO & Director

Thanks for having us, Tazeen.

Jeffrey P. Castelli
Amicus Therapeutics, Inc. - Chief Development Officer

Good afternoon.

Tazeen Ahmad
BofA Securities, Research Division - VP

So for the few people that might be on the webcast that aren't as familiar with Amicus. Maybe, Brad, you can give us like a 2-minute elevator pitch and all the things that are going on at the company, and then we can go into a little bit more detail.

Bradley L. Campbell
Amicus Therapeutics, Inc. - President, COO & Director

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot